Professional Bio
Dr. John Markman directs the Translational Pain Research Program in the Department of Neurosurgery and is an Associate Professor at the University of Rochester School of Medicine and Dentistry. Dr. Markman leads the Department of Neurosurgery's Neuromedicine Pain Management Center, a multi-specialty pain practice with a focus on patients with chronic pain associated with nerve injury. His practice and center offerings includes the gamut of medical, interventional, and behavioral therapies for chronic pain. His clinical research on chronic pain and low back pain have recently appeared in Journal of Pain, Pain, Clinical Pharmacology and Therapeutics, Rheumatology, Neurology, Anesthesiology Clinics of North America, Medical Clinics of North America, and Geriatric Clinics of North America in addition to numerous book chapters and non peer-reviewed publications.
Dr. Markman is Chairman-elect of the Pain and Palliative Care Section of the American Academy of Neurology, the guest editor of the recent Continuum Edition of Neuropathic Pain, a member of the editorial board of the Journal of Pain and an examiner for the American Board of Psychiatry and Neurology. He also serves as a special government employee of the Food and Drug Administration (FDA) and a member of the Anesthetic and LIfe Support Drug Advisory Committee. He lectures internationally and nationally on lumbar stenosis, chronic low back pain, opioid therapy, and neuropathic pain. Dr. Markman is board certified in Neuroolgy and has subspecialty board certification in Pain Management. He is a Fellow of the American Academy of Neurology.
Dr. Markman trained in Neurology at the Massachusetts General Hospital and the Brigham and Women's Hospital. His training in Pain Management was completed in the Department of Anesthesiology at Harvard's Beth Israel Deaconess Medical Center. He completed his medical degree at the University of Rochester School of Medicine & Dentistry where he was awared the Rudolph Angell Prize, the Robert J. Joynt Prize for Excellence in Clinical Neurology, and a member of AOA.
2012
Robert H. Dworkin; Dennis C. Turk; Sarah Peirce-Sandner; Laurie B. Burke;, John T. Farrar; Ian Gilron; Mark P. Jensen; Nathaniel P. Katz; Srinivasa N. Raja; Bob A. Rappaport; Michael C. Rowbotham; Misha-Miroslav Backonja; Ralf Baron;, Nicholas Bellamym; Zubin Bhagwagar; Ann Costello; Penney Cowan; Weikai Christopher Fang; Sharon Hertz; Gary W. Jay; Roderick Junor; Robert D. Kerns; Rosemary Kerwin; Ernest A. Kopecky; Dmitri Lissin; Richard Malamut; John D. Markman; Michael P. McDermott; Catherine Munera;. "Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations". 2012; . |
2012
D Turk; AB O'Connor; RH Dworkin; AChaudhry; NP Katz; EH Adams; JS Brownstein; SD Comer; R Dart; N Dasgupta; RA Denisco; M Klein; DB Leiderman; RLubran; BA Rappaport; JP Zacny; H Ahdieh; LB Burke; P Cowan; P Jacobs; R Malamut; J Markman; E Michna; P Palmer; S Peirce-Sandner; JS Potter; SN Raja; C Rauschkolb; CL Roland; LR Webster; RD Weiss; K Wolf. "Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations". Pain. 2012; . |
2011
Dworkin RH; Turk DC; Basch E; Berger A; Cleeland C; Farrar JT; Haythornthwaite JA; Jensen MP; Kerns RD; Markman J; Porter L; Raja SN; Ross E; Todd K; Wallace M; Woolf CJ. "Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy". Pain. 2011; 152: 1705-1708. |
2010
Markman, JD. "Bundle Up: It's Painful Out There - The Case for Opioid-Acetaminophen Combinations". Clinical Pharmacology & Therapeutics. 2010; 88(3): 292-294. |
2009
Markman, J.D.; Hanson, R.S. "The role of interventional therapy in the treatment of neuropathic pain". Continuum: Lifelong Learning in Neurology. 2009; 15(5): 101-133. |
